Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (391-400 of 822) with videos related to

Pageof 83
Sort By:
Food Research International (Ottawa, Ont.)|July 2, 2025
Multiphase gel-based functional inks in 3D food printing: A review on structural design and enhanced bioaccessibility of active ingredientsJinming Yu, Runkang Qiu, Wenbo Zheng, et al.
Frontiers in Immunology|April 30, 2024
Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancerJunhao Xu, Peiliang Wang, Yikun Li, et al.
Journal of Hepatocellular Carcinoma|September 13, 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World StudyXu Chang, Huiyong Wu, Shangkun Ning, et al.
Translational Lung Cancer Research|May 22, 2026
Impact of effective dose to immune cells (EDIC) on survival in limited-stage small cell lung cancer treated with radiotherapy and immunotherapyMengqian Jiang, Yuantao Qi, Zihong Zhu, et al.
Cancer Research|March 11, 2026
DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy EfficacyDong Pan, Meng Jiao, Yanyan Zhu, et al.
Hepato-Gastroenterology|April 11, 2007
Treatment of advanced hepatocellular carcinoma with gemcitabine plus oxaliplatinSheng Li, Zuoxing Niu, He Tian, et al.
International Journal of Clinical and Experimental Medicine|January 16, 2016
IL-21 polymorphisms rs907715 and rs2221903 are associated with decreased non-small cell lung cancer susceptibilityLanping Liu, Fang Shi, Shanshan Li, et al.
Journal of Global Health|February 13, 2025
The burden of COVID-19 death for different cancer types: a large population-based studyYou Mo, Duncan Wei, Xiaozheng Chen, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Oncotargets and Therapy|November 6, 2019
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case reportNing An, Haoyi Wang, Hui Zhu, et al.
Pageof 83

Showing results (391-400 of 822) with videos related to

Sort By:
Pageof 83
Food Research International (Ottawa, Ont.)|July 2, 2025
Multiphase gel-based functional inks in 3D food printing: A review on structural design and enhanced bioaccessibility of active ingredientsJinming Yu, Runkang Qiu, Wenbo Zheng, et al.
Frontiers in Immunology|April 30, 2024
Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancerJunhao Xu, Peiliang Wang, Yikun Li, et al.
Journal of Hepatocellular Carcinoma|September 13, 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World StudyXu Chang, Huiyong Wu, Shangkun Ning, et al.
Translational Lung Cancer Research|May 22, 2026
Impact of effective dose to immune cells (EDIC) on survival in limited-stage small cell lung cancer treated with radiotherapy and immunotherapyMengqian Jiang, Yuantao Qi, Zihong Zhu, et al.
Cancer Research|March 11, 2026
DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy EfficacyDong Pan, Meng Jiao, Yanyan Zhu, et al.
Hepato-Gastroenterology|April 11, 2007
Treatment of advanced hepatocellular carcinoma with gemcitabine plus oxaliplatinSheng Li, Zuoxing Niu, He Tian, et al.
International Journal of Clinical and Experimental Medicine|January 16, 2016
IL-21 polymorphisms rs907715 and rs2221903 are associated with decreased non-small cell lung cancer susceptibilityLanping Liu, Fang Shi, Shanshan Li, et al.
Journal of Global Health|February 13, 2025
The burden of COVID-19 death for different cancer types: a large population-based studyYou Mo, Duncan Wei, Xiaozheng Chen, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Oncotargets and Therapy|November 6, 2019
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case reportNing An, Haoyi Wang, Hui Zhu, et al.
Pageof 83